|Articles|September 1, 1998

September 1998
Volume 4
Issue 9

Assessing the Economic Value of Antihypertensive Medications

Author(s)Martin S. Roth, PhD, Robert C. Davenport, PhD, William Simpson, Jr., MD

Download PDF: Assessing the Economic Value of Antihypertensive Medications

Articles in this issue

almost 28 years ago

Article

Influence of a Critical Path Management Tool in the Treatment of Acute Myocardial Infarction

almost 28 years ago

Article

Infectious Diseases and Anemia in a Sample of Out-of-Treatment Drug Users

almost 28 years ago

Article

The Rationale for Skin Cancer Screening and Prevention

almost 28 years ago

Article

Effects of an Asthma Management Program on the Asthmatic Member: Patient-Centered Results of a 2-Year Study in a Managed Care Organization

almost 28 years ago

Article

Evaluating and Improving the Delivery of Heart Care: The University of Michigan Experience

almost 28 years ago

Article

A Case for Large-Core Biopsy Procedures in the Diagnosis of Breast Cancer

almost 28 years ago

Article

Mental Disorders in the Primary Care Sector: A Potential Role for Managed Care

almost 28 years ago

Article

Determining Whether Managed Care Formularies Meet the Needs of Pediatric Patients

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Assessing the Economic Value of Antihypertensive Medications

Articles in this issue

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Trending on AJMC

FDA Panel Backs 6 Peptides for Compounding

Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access

FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies